Effect of Angiotensin Receptor blockers on Insulin Resistance in End Stage Renal Disease Patients with Maintenance Hemodialysis

Phase 4

Completed

• Conditions: end stage renal disease; insulin resistance; insulin hypersensitivity; kidney disease; angiotensin receptor blocker

• Registration Number: TCTR20130901001
• Lead Sponsor: Phramongkutklao hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2013-06-30
• Study Start: 2013-09-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 35

Inclusion Criteria

Age> 18 year
Chronic hemodialysis at least 3 months
Adequate dialysis with spKt/V>1.2 and 3 time per weeks
No insulin treatment

Exclusion Criteria

all malignancy
active infection
congestive heart failure FC III-IV
recent cardiovascular disease or cerebrovascular disease with 3 months

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
insulin resistance 12 week HOMA-IR

Secondary Outcome Measures

Name	Time	Method
glucose metabolism 12 weeks fasting plasma glucose